RBC Capital Markets raised the price target for Exact Sciences stock on September 5, 2025.
2 reports, 1 independent
Updated Sep 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
RBC Capital Markets raised the price target for Exact Sciences stock on September 5, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
RBC Capital Markets
global investment bank
- Financial institutions like RBC and Macquarie maintained 'outperform' ratings amid dashed hopes for a Strait of Hormuz reopening.
- Kratos Defense & Security Solutions filed a shelf registration statement with the SEC, with Robert W. Baird & Co. and RBC Capital Markets acting as joint book-running managers.
-
Exact Sciences
American company in Madison, United States
Related events
- Multiple financial analysts, including RBC and Morgan Stanley, issued target changes for various companies following recent financial reports.
- Analyst firms provided guidance and market commentary on August 1, 2026, involving RBC Capital Markets and CSL Limited.
- RBC Capital Markets advised LCN Capital Partners in a recent deal.
- RBC Capital Markets initiated coverage of Dell with an Outperform rating.
- RBC Capital Markets initiated coverage of Atlassian with an Outperform rating on August 26, 2026.
Coverage
Newest first; wire copies grouped- StockStoryWhy Exact Sciences (EXAS) Stock Is Trading Up Today Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 6.3% in the afternoon session after extending its positive momentum as
- StockStoryExact Sciences (EXAS) Stock Trades Up, Here Is Why Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 1.5% in the afternoon session after RBC Capital Markets raised its pric